HomeALLO • NASDAQ
add
Allogene Therapeutics Inc
Previous close
$1.12
Day range
$1.02 - $1.12
Year range
$0.86 - $3.78
Market cap
231.85M USD
Avg Volume
4.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.99M | -13.18% |
Net income | -59.73M | 8.10% |
Net profit margin | — | — |
Earnings per share | -0.28 | 26.32% |
EBITDA | -62.09M | 5.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 280.04M | -27.24% |
Total assets | 507.98M | -13.37% |
Total liabilities | 122.59M | -1.92% |
Total equity | 385.39M | — |
Shares outstanding | 218.73M | — |
Price to book | 0.64 | — |
Return on assets | -30.85% | — |
Return on capital | -33.02% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -59.73M | 8.10% |
Cash from operations | -52.93M | 5.31% |
Cash from investing | 6.18M | -72.10% |
Cash from financing | 13.99M | 747.88% |
Net change in cash | -32.76M | -2.01% |
Free cash flow | -31.91M | 7.23% |
About
Founded
2017
Headquarters
Website
Employees
226
